Results 241 to 250 of about 3,006,184 (303)

Pulmonary hypertension in patients with chronic myeloproliferative disorders

European Respiratory Journal, 2010
Y. Adir, M. Humbert
semanticscholar   +1 more source

Activating Mutations in Protein Tyrosine Phosphatase Ptpn11 (Shp2) Enhance Reactive Oxygen Species Production That Contributes to Myeloproliferative Disorder

, 2013
Dan Xu, Hong Zheng, Wen-Mei Yu, Cheng‐Kui Qu   +3 more
openalex   +2 more sources

Somatic mutations of JAK2 exon 12 in patients with JAK2 (V617F)-negative myeloproliferative disorders.

Blood, 2008
D. Pietra, Sai Li, Angela Brisci, F. Passamonti, E. Rumi, A. Theocharides, M. Ferrari, H. Gisslinger, R. Kralovics, L. Cremonesi, R. Skoda, M. Cazzola   +11 more
semanticscholar   +1 more source

JAK Kinase Inhibitors as Possible Treatment for Myeloproliferative Disorders and Cancer

, 2012
Ahmed F. Abdel‐Magid
openalex   +1 more source

Ocular manifestations in leukemia and myeloproliferative disorders and their association with hematological parameters.

Ann Afr Med, 2016
Dhasmana R, Prakash A, Gupta N, Verma SK.   +3 more
europepmc   +1 more source

A Single Mutation in the Myeloproliferative Group of Disorders-0

, 2011
Donal P. McLornan, Melanie J. Percy, Mary Frances McMullin   +2 more
openalex   +1 more source

Behçet-like Syndromes: A Comprehensive Review. [PDF]

Dermatopathology (Basel)
Mancuso G, Salvadè I, Ogna A, Balestra B, Beltraminelli H.   +4 more
europepmc   +1 more source

Trombose Venosa Esplâncnica: Factores de Risco [PDF]

, 2012
Tiago Alexandre Espada Guerreiro
core  

Case Report: Late Hypersensitivity Reaction to Hydroxyurea in a Patient With Myeloproliferative Disorder. [PDF]

Case Rep Hematol
Kahlon N, Baddam S, Kaur H, Singh P, Qureshi Z, Gowda AM.   +5 more
europepmc   +1 more source